Supernus Pharmaceuticals reported that a negative accrual ratio indicated that statutory earnings were less than free cash flow as of August 13, 2025.
1 report, 1 independent
Updated Aug 13
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Supernus Pharmaceuticals reported that a negative accrual ratio indicated that statutory earnings were less than free cash flow as of August 13, 2025.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Supernus Pharmaceuticals (United States)
company in Rockville, United States
Nothing else this week.
Coverage
Newest first; wire copies grouped- Simply Wall St.Statutory Profit Doesn't Reflect How Good Supernus Pharmaceuticals' (NASDAQ:SUPN) Earnings Are Explore Supernus Pharmaceuticals's Fair Values from the Community and select yours Supernus Pharmaceutic